ACLARION, INC. Depreciation
ACLARION, INC. (ACON) reported Depreciation of $1.45 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- ACLARION, INC. depreciation for the quarter ending 2026-06-30 was $1.45K, a 210.52% increase year-over-year.
- ACLARION, INC. depreciation for the quarter ending 2025-06-30 was $466.00.
- ACLARION, INC. depreciation for fiscal 2025 was $2.86K, a 104.29% increase from fiscal 2024.
- ACLARION, INC. depreciation for fiscal 2024 was $1.40K, a 10.55% decline from fiscal 2023.
- ACLARION, INC. depreciation for fiscal 2023 was $1.56K, a 65.24% decline from fiscal 2022.
- ACLARION, INC. depreciation for fiscal 2022 was $4.50K, a 65.33% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 12 month |
|---|---|---|---|
| 2026-06-30 | $1.45K 10-Q · filed 2026-08-06 | $2.74K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $2.86K 10-K · filed 2026-03-18 | ||
| 2025-06-30 | $466.00 10-Q · filed 2026-08-06 | $871.00 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $1.40K 10-K · filed 2026-03-18 | ||
| 2023-12-31 | $1.56K 10-K · filed 2025-04-09 | ||
| 2022-12-31 | $4.50K 10-K · filed 2024-03-28 | ||
| 2021-12-31 | $12.98K 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |